The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Zachary Frosch named assistant professor at Fox Chase

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Zachary Frosch was named assistant professor within the Department of Hematology/Oncology at Fox Chase Cancer Center.

Frosch is a graduate of the Perelman School of Medicine at the University of Pennsylvania and completed his residency in internal medicine at Brigham and Women’s Hospital.

Following his residency, he served from 2017 to 2018 as associate director of the Scholars in Medical Education Pathway, as an instructor in medicine at Harvard Medical School, and as a physician in the Dana-Farber Cancer Institute’s Division of Oncology Hospital Medicine. He was also named a scholar in the Harvard Macy Program for Educators in the Health Professions at Harvard Medical School.

Frosch will begin work at Fox Chase on Aug. 1.

Table of Contents

YOU MAY BE INTERESTED IN

ClinicalRegulatory NewsTrials & Tribulations

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL). 
By Edison T. Liu
Sponsored

Why both somatic and germline genomic profiling are essential for precision oncology

Over the past three decades, cancer genetics has transformed precision oncology. Germline testing has advanced from single-gene Sanger sequencing to parallel sequencing of hundreds of genes, while tumor (somatic) testing has expanded with the rise of targeted therapies based on point mutations, copy number changes and other alterations. 
By Heather Hampel and David W. Craig
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account